M&A Deal Summary

Allergan Acquires Specifar Pharmaceuticals S.A.

On May 25, 2011, Allergan acquired life science company Specifar Pharmaceuticals S.A. for 400M EUR

Acquisition Highlights
  • This is Allergan’s 5th transaction in the Life Science sector.
  • This is Allergan’s 13th largest (disclosed) transaction.
  • This is Allergan’s 1st transaction in Greece.

M&A Deal Summary
Date 2011-05-25
Target Specifar Pharmaceuticals S.A.
Sector Life Science
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 400M EUR
Advisor(s) Rothschild Global Advisory
Eurobank Equities (Financial)

Target

Specifar Pharmaceuticals S.A.

Athens, Greece
Specifar is a multinational generic pharmaceuticals company with its headquarters in Greece and representative offices in Europe. Specializing in development, production, distribution and sales & marketing, Specifar commits to delivering high-quality and affordable medicines to patients and its customers. Specifar employs approximately 460 people worldwide and has obtained more than 600 Marketing Authorizations in Europe, South Africa, Canada, the Middle East and Asia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 9 of 38
Sector (Life Science) 5 of 23
Type (Add-on Acquisition) 8 of 31
Country (Greece) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 13 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-07-28 GeneraMedix Pharmaceuticals

Libert Corner, New Jersey, United States

GeneraMedix Pharmaceuticals, based in Liberty Corner, New Jersey, is an international generic pharmaceutical company primarily focused on the development and sale of injectable products utilized in hospitals and specialty clinics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-04-25 Actavis Group

Zug, Switzerland

Actavis is a generic pharmaceutical companies, specializing in the development, manufacture and sale of generic pharmaceuticals. The company has operations in more than 40 countries, with over 10,000 employees. At present, Actavis has a portfolio which includes more than 1,000 medicines present on the market and registered in more than 70 countries.

Buy €4.3B
Mergr

Product

Company

Legal